Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)

Albert Fournier, Roxana Oprisiu, Jean Michel Achard, Olaf H. Klungel, Hubert G.M. Leufkens, Anthonius De Boer, W. T. Longstreth, Robert C. Kaplan, Nicholas L. Smith, Bruce M. Psaty

Research output: Contribution to journalLetterpeer-review

Fingerprint Dive into the research topics of 'Differences between primary vs secondary prevention trials regarding the stroke protective effect of antihypertensive drugs [3] (multiple letters)'. Together they form a unique fingerprint.